The Immune Landscape of Colorectal Cancer

While the clinical importance of CD8+ and CD3+ cells in colorectal cancer (CRC) is well established, the impact of other immune cell subsets is less well described. We sought to provide a detailed overview of the immune landscape of CRC in the largest study to date in terms of patient numbers and in...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Artur Mezheyeuski, Patrick Micke, Alfonso Martín-Bernabé, Max Backman, Ina Hrynchyk, Klara Hammarström, Simon Ström, Joakim Ekström, Per-Henrik Edqvist, Magnus Sundström, Fredrik Ponten, Karin Leandersson, Bengt Glimelius, Tobias Sjöblom
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/aa7f515e58784ff3830be91b167a84e4
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:aa7f515e58784ff3830be91b167a84e4
record_format dspace
spelling oai:doaj.org-article:aa7f515e58784ff3830be91b167a84e42021-11-11T15:34:27ZThe Immune Landscape of Colorectal Cancer10.3390/cancers132155452072-6694https://doaj.org/article/aa7f515e58784ff3830be91b167a84e42021-11-01T00:00:00Zhttps://www.mdpi.com/2072-6694/13/21/5545https://doaj.org/toc/2072-6694While the clinical importance of CD8+ and CD3+ cells in colorectal cancer (CRC) is well established, the impact of other immune cell subsets is less well described. We sought to provide a detailed overview of the immune landscape of CRC in the largest study to date in terms of patient numbers and in situ analyzed immune cell types. Tissue microarrays from 536 patients were stained using multiplexed immunofluorescence panels, and fifteen immune cell subclasses, representing adaptive and innate immunity, were analyzed. Overall, therapy-naïve CRC patients clustered into an ‘inflamed’ and a ‘desert’ group. Most T cell subsets and M2 macrophages were enriched in the right colon (<i>p</i>-values 0.046–0.004), while pDC cells were in the rectum (<i>p</i> = 0.008). Elderly patients had higher infiltration of M2 macrophages (<i>p</i> = 0.024). CD8+ cells were linked to improved survival in colon cancer stages I-III (q = 0.014), while CD4+ cells had the strongest impact on overall survival in metastatic CRC (q = 0.031). Finally, we demonstrated repopulation of the immune infiltrate in rectal tumors post radiation, following an initial radiation-induced depletion. This study provides a detailed analysis of the in situ immune landscape of CRC paving the way for better diagnostics and providing hints to better target the immune microenvironment.Artur MezheyeuskiPatrick MickeAlfonso Martín-BernabéMax BackmanIna HrynchykKlara HammarströmSimon StrömJoakim EkströmPer-Henrik EdqvistMagnus SundströmFredrik PontenKarin LeanderssonBengt GlimeliusTobias SjöblomMDPI AGarticlecolorectal cancermultiplextumor immunologyimmune landscapeNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENCancers, Vol 13, Iss 5545, p 5545 (2021)
institution DOAJ
collection DOAJ
language EN
topic colorectal cancer
multiplex
tumor immunology
immune landscape
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle colorectal cancer
multiplex
tumor immunology
immune landscape
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Artur Mezheyeuski
Patrick Micke
Alfonso Martín-Bernabé
Max Backman
Ina Hrynchyk
Klara Hammarström
Simon Ström
Joakim Ekström
Per-Henrik Edqvist
Magnus Sundström
Fredrik Ponten
Karin Leandersson
Bengt Glimelius
Tobias Sjöblom
The Immune Landscape of Colorectal Cancer
description While the clinical importance of CD8+ and CD3+ cells in colorectal cancer (CRC) is well established, the impact of other immune cell subsets is less well described. We sought to provide a detailed overview of the immune landscape of CRC in the largest study to date in terms of patient numbers and in situ analyzed immune cell types. Tissue microarrays from 536 patients were stained using multiplexed immunofluorescence panels, and fifteen immune cell subclasses, representing adaptive and innate immunity, were analyzed. Overall, therapy-naïve CRC patients clustered into an ‘inflamed’ and a ‘desert’ group. Most T cell subsets and M2 macrophages were enriched in the right colon (<i>p</i>-values 0.046–0.004), while pDC cells were in the rectum (<i>p</i> = 0.008). Elderly patients had higher infiltration of M2 macrophages (<i>p</i> = 0.024). CD8+ cells were linked to improved survival in colon cancer stages I-III (q = 0.014), while CD4+ cells had the strongest impact on overall survival in metastatic CRC (q = 0.031). Finally, we demonstrated repopulation of the immune infiltrate in rectal tumors post radiation, following an initial radiation-induced depletion. This study provides a detailed analysis of the in situ immune landscape of CRC paving the way for better diagnostics and providing hints to better target the immune microenvironment.
format article
author Artur Mezheyeuski
Patrick Micke
Alfonso Martín-Bernabé
Max Backman
Ina Hrynchyk
Klara Hammarström
Simon Ström
Joakim Ekström
Per-Henrik Edqvist
Magnus Sundström
Fredrik Ponten
Karin Leandersson
Bengt Glimelius
Tobias Sjöblom
author_facet Artur Mezheyeuski
Patrick Micke
Alfonso Martín-Bernabé
Max Backman
Ina Hrynchyk
Klara Hammarström
Simon Ström
Joakim Ekström
Per-Henrik Edqvist
Magnus Sundström
Fredrik Ponten
Karin Leandersson
Bengt Glimelius
Tobias Sjöblom
author_sort Artur Mezheyeuski
title The Immune Landscape of Colorectal Cancer
title_short The Immune Landscape of Colorectal Cancer
title_full The Immune Landscape of Colorectal Cancer
title_fullStr The Immune Landscape of Colorectal Cancer
title_full_unstemmed The Immune Landscape of Colorectal Cancer
title_sort immune landscape of colorectal cancer
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/aa7f515e58784ff3830be91b167a84e4
work_keys_str_mv AT arturmezheyeuski theimmunelandscapeofcolorectalcancer
AT patrickmicke theimmunelandscapeofcolorectalcancer
AT alfonsomartinbernabe theimmunelandscapeofcolorectalcancer
AT maxbackman theimmunelandscapeofcolorectalcancer
AT inahrynchyk theimmunelandscapeofcolorectalcancer
AT klarahammarstrom theimmunelandscapeofcolorectalcancer
AT simonstrom theimmunelandscapeofcolorectalcancer
AT joakimekstrom theimmunelandscapeofcolorectalcancer
AT perhenrikedqvist theimmunelandscapeofcolorectalcancer
AT magnussundstrom theimmunelandscapeofcolorectalcancer
AT fredrikponten theimmunelandscapeofcolorectalcancer
AT karinleandersson theimmunelandscapeofcolorectalcancer
AT bengtglimelius theimmunelandscapeofcolorectalcancer
AT tobiassjoblom theimmunelandscapeofcolorectalcancer
AT arturmezheyeuski immunelandscapeofcolorectalcancer
AT patrickmicke immunelandscapeofcolorectalcancer
AT alfonsomartinbernabe immunelandscapeofcolorectalcancer
AT maxbackman immunelandscapeofcolorectalcancer
AT inahrynchyk immunelandscapeofcolorectalcancer
AT klarahammarstrom immunelandscapeofcolorectalcancer
AT simonstrom immunelandscapeofcolorectalcancer
AT joakimekstrom immunelandscapeofcolorectalcancer
AT perhenrikedqvist immunelandscapeofcolorectalcancer
AT magnussundstrom immunelandscapeofcolorectalcancer
AT fredrikponten immunelandscapeofcolorectalcancer
AT karinleandersson immunelandscapeofcolorectalcancer
AT bengtglimelius immunelandscapeofcolorectalcancer
AT tobiassjoblom immunelandscapeofcolorectalcancer
_version_ 1718435202012807168